Real-World Results For GLP-1 Drugs Underwhelm, Study Says
By Dennis Thompson HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic,…
Why Omada Health is resisting an AI takeover after its IPO
Omada Health’s president Wei-Li Shao and CEO Sean Duffy at the company’s June 6 IPO. Omada Health AI is taking over healthcare, but Omada Health is pushing back. Unlike some of its peers, Omada Health says it won’t let AI take over care delivery. The chronic care startup went public on Friday, marking the second […]
How to keep weight off after obesity drugs
Nature, Published online: 11 June 2025; doi:10.1038/d41586-025-01770-0 Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected
GLP-1 investors haven’t gained as much as expected from others’ losses. Since the FDA approved Wegovy, also known as semaglutide, as an injectactable treatment to help people manage their weight, several exchange-traded funds tracking the performance of the company and its rivals in GLP-1 medications have largely failed to reflect the massive popularity of the drugs […]
‘Pharma is eating Big Food’s lunch…’ Lembas fights back with GLP-1 boosting peptide
Israeli foodtech startup Lembas has emerged from stealth with “GLP-1 Edge,” a bioactive peptide that triggers the production of GLP-1 and other gut hormones that regulate appetite and metabolism. Founded in 2024 by Shay Hilel (CEO), Dr. Zohar Barbash (CTO), Prof. Maayan Gal (CSO) and Dr. Daniel Bar, Lembas has raised a $3.6 million pre-seed […]
Novo Nordisk’s Canadian Mistake
This was an interesting interview with Richard Saynor, the head of Sandoz (which is now an independent generics company). That’s a part of the industry that I don’t cover as much, partly because I’ve never worked in it and partly because it can be a very different world than the new-drug-discovery-oriented pharma one that I […]
Less Real-World GLP-1 Weight Loss; TROA Support; Rebuttal to Vitamin D Guidelines
(MedPage Today) — Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in real-world settings versus what is reported in clinical trials, likely because patients discontinue treatment…
McDonald’s is facing a harsh new reality as customer behavior shifts
When it was first founded in 1940 as a burger joint selling 15-cent sandwiches, it was hard to imagine that McDonald’s (MCD) would eventually grow into the world’s biggest fast-food chain. But McDonald’s has carefully curated its offerings over the years, sticking to a robust menu of classics while finding ways to introduce new items […]
I Let This App Dictate My Workouts Based on My DNA – Was It Worth It?
I’ve done plenty of DNA tests to help me explore my heritage a little deeper (I’m a hodgepodge of Eastern European, in case you’re wondering). I love learning about what makes me, me. But I never thought my genetic makeup could influence my workouts. Then, I got wind of Alter, a fitness program that tests […]
Doctors Concerned By Massive Uptick In Teens Taking Ozempic
Teens are being prescribed Ozempic and similar drugs more than ever before — and some doctors are worried about what the trend could mean. In interviews with Reuters and Raleigh, North Carolina’s WRAL, doctors expressed disquiet at recent studies that found that are kids being prescribed the uber-popular jabs at increasing rates. Two recent studies, the […]